[1]CurrentPatentAssignee:Novartis(w/oSandoz);UNIVERSITYOFCALIFORNIA;NOVARTISAG-WO2020/146779,2020,A1Locationinpatent:Paragraph0593;0596;0604;0607
519004-34-3
60252-77-9
75001-47-7
946826-47-7
1156158-72-3
521074-20-4
937688-27-2 | 6-Fluoro-2-oxo-2h-chromene-3-carboxylic acid | AA019RY1 | MFCD08753858
883542-53-8 | 1-[(1-aminopropan-2-yl)oxy]-3-fluorobenzene | AA019S2U | MFCD06247713
1354963-03-3 | 3-(1,2,3,4-tetrahydroisoquinolin-5-yl)-1,3-oxazolidin-2-one hydrochloride | AA019S8P | MFCD20502017
1375184-09-0 | ethyl 2-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]acetate | AA019SDT | MFCD21602455
1375473-65-6 | 1-{[3-(methoxymethyl)phenyl]sulfanyl}-N,N-dimethylformamide | AA019SJS | MFCD21602456
1038335-01-1 | 4-[(3-methylbut-2-enamido)methyl]benzoic acid | AA019SRE | MFCD11202664
1156154-87-8 | N-(4-chloro-3-cyanophenyl)prop-2-enamide | AA019SWR | MFCD12091347
1250678-07-9 | N-methyl-2-(2-oxopiperazin-1-yl)acetamide | AA019T16 | MFCD16706542
1097812-58-2 | 1,4-Dioxane-2-carbohydrazide | AA019T5H | MFCD11645181
1376333-10-6 | 4-Bromo-3-ethyl-1H-pyrazol-5-amine | AA019TA3 | MFCD08669406